All > Multiple Sclerosis

PMT/Blackrock Combination Device for Spinal Cord Injury

University of California San Francisco, San Francisco, CA
Spinal Cord Injury+4 More ConditionsPMT/Blackrock Combination Device - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether electrical signals from the brain can be used to control devices for motor and speech control in adults with severe neurological disorders.

Eligible Conditions
  • Spinal Cord Injury
  • Lou Gehrig's Disease
  • Multiple Sclerosis
  • Stroke
  • Muscular Dystrophy

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
Phase < 1

Similar Trials

1
ABBV-CLS-7262
1
18F-OP-801
1
Low Oxygen therapy

Study Objectives

3 Primary · 2 Secondary · Reporting Duration: Up to 6 years post-implant period

Year 6
Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]
NIDCD Primary Objective 1
NIDCD Primary Objective 2
NIDCD Secondary Objective 1
NIDCD Secondary Objective 2

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
ABBV-CLS-7262
1
18F-OP-801
1
Low Oxygen therapy

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

Electrocorticography-based brain computer interface
1 of 1

Experimental Treatment

3 Total Participants · 1 Treatment Group

Primary Treatment: PMT/Blackrock Combination Device · No Placebo Group · Phase < 1

Electrocorticography-based brain computer interface
Device
Experimental Group · 1 Intervention: PMT/Blackrock Combination Device · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 6 years post-implant period

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,347 Previous Clinical Trials
11,783,109 Total Patients Enrolled
Karunesh Ganguly, MD, PhDPrincipal Investigator - University of California, San Francisco
San Francisco VA Medical Center, UCSF Medical Center at Parnassus
University Of California (Medical School)
University Ca Sf School Of Medicine (Residency)
1 Previous Clinical Trials
25 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a condition that affects the use of your arms, such as stroke, ALS, multiple sclerosis, spinal cord injury or severe nerve or muscle problems.
If you have had a stroke or spinal cord injury, you must have recovered for at least one year since the onset of symptoms.
References

Frequently Asked Questions

Is this experiment still open to participation?

"Affirmative. The clinicaltrials.gov records indicate that the enrollment of subjects for this research is currently ongoing, with a first post date of November 9th 2018 and last update on July 29th 2022. 3 patients are sought from one medical centre." - Anonymous Online Contributor

Unverified Answer

What is the present capacity for enrollment into this experiment?

"Indeed, the data hosted on clinicaltrials.gov states that this medical experiment is presently recruiting; first posted November 9th 2018 and most recently updated July 29th 2022 with a need of 3 participants across one site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top